Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain
Status:
NOT_YET_RECRUITING
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
To assess the 1-month effects and safety of esketamine - PRF -standardized drug treatment against PRF -standardized drug treatment acute/subacute zoster-associated pain (ZAP) patients.
Phase:
NA
Details
Lead Sponsor:
Beijing Tiantan Hospital
Collaborators:
Beijing Ditan Hospital Beijing Xiaotangshan Hospital Hengshui People's Hospital The First Hospital of Fangshan District,Beijing